Short term results of cementless total hip arthroplasty in sicklers

Gulati, Yash; Sharma, Mrinal; Bharti, B.; Bahl, Vibhu; Bohra, Ishwar; Goswani, Amit

doi:10.4103/0019-5413.159659

Cited by 11 publications

(3 citation statements)

References 23 publications

(31 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…They did not observe any significant difference compared to a cohort of THAs performed for ON related to other causes. Gulati et al [ 11 ] observed a mean follow-up of 3.8 years in 50 THAs and have not encountered any cases of infection, dislocation or aseptic loosening.…”

Section: Discussionmentioning

confidence: 99%

Total hip arthroplasty in osteonecrosis secondary to sickle cell disease

Farook

Awogbade

Somasundaram

et al. 2018

International Orthopaedics (SICOT)

View full text Add to dashboard Cite

Background Sickle cell disease (SCD) is a multisystem disease, and the predominant articular manifestation is osteonecrosis (ON). Total hip arthroplasty (THA) is technically challenging, and the complication rates are high. In this retrospective study, we have analysed the outcome of THA in a cohort of patients with SCD at our institution. Materials and methods We identified 34 THAs between 1999 and 2016 in 30 patients (mean age 37 years) from our SCD database. Co-morbidities, both sickle and non-sickle-related, were documented. Complications and indications for revision surgery were analysed. Results An uncemented prosthesis was predominantly used. The mean follow-up was 10.5 years (range 1-18). Six patients had revision surgery (17.6%), 2 (5.8%) for Prosthetic Joint Infection (PJI), and 4 (11.7%) for osteolysis of the acetabular component. Conclusion Our revision rates were comparable to the published literature. Our combined sickle cell clinic and the coordinated multidisciplinary management have been successful in reducing morbidity.

show abstract

Section: Discussionmentioning

confidence: 99%

Total hip arthroplasty in osteonecrosis secondary to sickle cell disease

Farook

Awogbade

Somasundaram

et al. 2018

International Orthopaedics (SICOT)

View full text Add to dashboard Cite

show abstract

“…This was a retrospective study, so the analyses of the surgical complications were limited by a lack of clinical detail. Additionally, the published studies we reviewed contained low levels of evidence: the majority were non-randomized retrospective case series reporting outcomes over the last 40-50 years [26][27][28][29][30].…”

Section: Discussionmentioning

confidence: 99%

Intraoperative Periprosthetic Fractures in Total Hip Arthroplasty in Patients With Sickle Cell Disease at King Fahad Hospital Hofuf: A Cross-Sectional Study

Alsaleem

Alalwan

Alkhars

et al. 2020

Cureus

View full text Add to dashboard Cite

Background Patients with avascular necrosis related to sickle cell disease (SCD) can be severely disabled by the severe degenerative changes of their hip. Total hip arthroplasty (THA) remains the only surgical option for some of these patients. Total hip arthroplasty can be a challenging procedure, and SCD patients demonstrate high percentages of medical, intraoperative, and postoperative complications and implant failure. Furthermore, the need for THA following avascular necrosis in the Eastern Province of Saudi Arabia is high, and the subsequent risk of periprosthetic fracture is prevalent. Therefore, it is crucial to conduct such a study. Aim of the study This cross-sectional retrospective study aimed to assess the prevalence and associated risk factors for periprosthetic fractures during total hip arthroplasty in sickle cell disease patients at King Fahad Hospital Hofuf, Saudi Arabia. Methods We collected the data of all SCD patients who had undergone THA during the study period, January 2015 to September 2020. Forty-nine SCD patients who had undergone THA during the study period were included. Patients who had undergone hip hemiarthroplasty, postoperative fractures, or had an indication of THA other than avascular necrosis were excluded. Surgeon factors, assistant factors, and surgical technique were also excluded. We then analyzed the data according to gender, age, BMI, American Society of Anesthesiologists classification, implant fixation type, avascular necrosis stage, proximal femoral morphology, Vancouver classification type, sickle cell type, preoperative hemoglobin (Hb) level, and the risk of periprosthetic fractures. Descriptive statistics were presented using frequency and percentages for categorical variables, and continuous variables were summarized using means ± standard deviations. Independent t-tests and chi-square tests were used to test for associations between categorical variables. At 0.05, the significance level was set. Results Of the patients, 32.7% were male and 67.3% were female. 32.7% of the patients had advanced degenerative changes due to avascular necrosis. Among the patients, 20.4% had an intraoperative periprosthetic femoral fracture, 90% had a Vancouver classification class A, and 10% had a Vancouver classification class B1. According to Dorr classification, 75.5% were classified as Dorr A and 24.5% as Dorr B. Of the patients, 48 had an uncemented implant, and only 1 had cemented. The mean perioperative Hb was 9.02 + 2.02, with a minimum of 6 and a maximum of 14. No significant associations were found between the incidence of intraoperative femoral fracture and the demographic variables and the operative profile characteristics. However, a significantly higher rate of fracture was observed in patients operated on the right side compared to patients operated on the left side. Conclusion The prevalence of periprosthetic intraoperative fracture among SCD patients at King Fahad H...

show abstract

“…The most important limits of these recommendations are due to the fact that articles from the literature come from America, Europe, and the Middle-East, while nearly 90% of the world’s SCD population lives in three countries: Nigeria, India, and the Democratic Republic of Congo; and the English-language literature does not give many data about THA in these countries. 22 …”

Section: Methodsmentioning

confidence: 99%

Total hip arthroplasty for sickle cell osteonecrosis: guidelines for perioperative management

et al. 2020

View full text Add to dashboard Cite

The prognosis of sickle cell disease (SCD) has greatly improved in recent years, resulting in an increased number of patients reporting musculoskeletal complications such as osteonecrosis of the femoral head. Total hip arthroplasty (THA) can be utilized to alleviate the pain associated with this disease. Although it is well known that hip arthroplasty for avascular necrosis (AVN) in SCD may represent a challenge for the surgeon, complications are frequent, and no guidelines exist to prevent these complications. Because patients with SCD will frequently undergo THA, we thought it necessary to fulfil the need for guidance recommendations based on experience, evidence and agreement from the literature. For all these reasons this review proposes guidelines that provide clinicians with a document regarding management of patients with SCD in the period of time leading up to primary THA. The recommendations provide guidance that has been informed by the clinical expertise and experience of the authors and available literature. Although this is not a systematic review since some papers may have been published in languages other than English, our study population consisted of 5,868 patients, including 2,126 patients with SCD operated on for THA by the senior author in the same hospital during 40 years and 3,742 patients reported in the literature. Cite this article: EFORT Open Rev 2020;5:641-651. DOI: 10.1302/2058-5241.5.190073

show abstract

Short term results of cementless total hip arthroplasty in sicklers

Cited by 11 publications

References 23 publications

Total hip arthroplasty in osteonecrosis secondary to sickle cell disease

Total hip arthroplasty in osteonecrosis secondary to sickle cell disease

Intraoperative Periprosthetic Fractures in Total Hip Arthroplasty in Patients With Sickle Cell Disease at King Fahad Hospital Hofuf: A Cross-Sectional Study

Total hip arthroplasty for sickle cell osteonecrosis: guidelines for perioperative management

Contact Info

Product

Resources

About